What is CVE-2023-38954?

CVE-2023-38954 is a critical-severity vulnerability in Zkteco Bioaccess Ivs, classified under SQL Injection. CVSS score: 9.8/10. Published 2023-08-03.

How severe is CVE-2023-38954?

Critical severity. CVSS v3 base score is 9.8 out of 10.

SQL Injection in Zkteco Bioaccess Ivs

CVE-2023-38954

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

Vulnerability class: SQL Injection

Published 2023-08-03 · last modified 2026-07-09.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.006 (47.0th percentile), scored 2026-09-30.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 47th percentile — 47.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: +0.000

Affected products

Zkteco Bioaccess Ivs — versions 3.3.1

Weakness classification (CWE)

CWE-89 — SQL Injection

References

af854a3a-2127-422b-91ae-364da2661108 (Not Applicable)
claroty.com/team82/disclosure-dashboard/cve-2023-38954 (Third Party Advisory)

Frequently asked questions

What is CVE-2023-38954?: CVE-2023-38954 is a critical-severity vulnerability in Zkteco Bioaccess Ivs, classified under SQL Injection. CVSS score: 9.8/10. Published 2023-08-03.
How severe is CVE-2023-38954?: Critical severity. CVSS v3 base score is 9.8 out of 10.